<a href="https://laohu8.com/S/MRSN">Mersana Therapeutics Inc.</a> Receives Nasdaq Notice for Non-Compliance with Market Value Listing Rule
Mersana Therapeutics Inc. announced that it has received a notice from the Nasdaq Stock Market's Listing Qualifications Department, indicating that the company is not in compliance with the Nasdaq Listing Rule 5450(b)(2)$(A)$. This rule requires Mersana to maintain a minimum Market Value of Listed Securities (MVLS) of $50 million. The notice, received on September 5, 2025, serves as a notification of deficiency but does not indicate an imminent delisting of the company's common stock, which continues to trade under the symbol "MRSN" on the Nasdaq Global Select Market. Mersana has until March 4, 2026, to regain compliance by achieving an MVLS of $50 million or more for at least ten consecutive business days. Failure to meet this requirement could result in delisting, although the company would have the opportunity to appeal. Mersana is monitoring the situation and exploring options to regain compliance.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mersana Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-087800), on September 05, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.